MatsukiyoCocokara & Co.

3088.T
Pharmaceutical Retailers
2026/08/10 Updated
Market Cap: $6.2B (¥979.2B)
Stock Price: $15.76 (¥2,490)
Exchange Rate: 1 USD = ¥157.98

Dividend Increase and 2027 Earnings Outlook | May 13, 2026

The Company has increased the year-end dividend for the 2026 fiscal year to 26 yen and set the annual dividend forecast for the 2027 fiscal year at 56 yen. The dividend increase is based on the company's performance and management’s shareholder return policy.

Importance:
Page Updated: May 13, 2026
IR Disclosure Date: May 13, 2026

Key Figures

  • Dividend per share (2026 fiscal year): 26 yen
  • Total dividends for 2026 fiscal year: 10,363 million yen
  • Dividend forecast (2027 fiscal year, annual): 56 yen

AI要約

Performance and Dividend Overview

The Company increased the year-end dividend for the 2026 fiscal year from 24 yen to 26 yen, with total dividends amounting to 10,363 million yen. The dividend forecast for the 2027 fiscal year is set at an annual 56 yen, reflecting a 6 yen increase from the previous year's 50 yen. The increase is driven by the company’s shareholder return policy, targeting a 6% return on net assets and a payout ratio of 50%, based on performance and economic conditions.

Shareholder Return and Future Outlook

The Company utilizes retained earnings as the main source for dividends and maintains a policy of progressive dividends. Considering the company's performance for the 2026 fiscal year, the forecast for 2027, and economic conditions, the year-end dividend was increased by 2 yen, setting an annual dividend of 56 yen. The Company aims to continue sustainable shareholder returns with stable and increasing dividends in the future.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Mas Ke Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →